Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to ...

Miyake and Masakatsu Yamashita has discovered that Bach2, a protein essential for regulating T cells function, plays a ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD ... "Bempikibart has a proposed mechanism ...

Learn how ultrafine bubble showers can improve eczema symptoms by reducing inflammation and enhancing skin barrier proteins.

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic ...

Atopic dermatitis (AD) is a chronic inflammatory skin disease with high prevalence, especially in children. Current ...

ATOPIC dermatitis (AD) is the most common chronic inflammatory skin condition, affecting up to 10% of adults and up to 20% of ...

Dupixent (dupilumab) is a brand-name subcutaneous injection that’s prescribed for atopic dermatitis, asthma, and more. It works to treat those conditions by blocking proteins that cause ...

"The proposed mechanism of action of rocatinlimab ... by targeting OX40+ T cells in patients with moderate-to-severe atopic dermatitis: Results from the phase III ROCKET-Horizon trial" AAD ...

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in May Initial Results From First Two Cohorts Supports Safety and Efficacy with Oral Agent and ...